ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biodurable Ophthalmic Drug Delivery System Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-20R14499
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biodurable Ophthalmic Drug Delivery System Market Research Report 2023
BUY CHAPTERS

Global Biodurable Ophthalmic Drug Delivery System Market Research Report 2025

Code: QYRE-Auto-20R14499
Report
February 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Glaukos Corp
Ocular Therapeutix
Santen Pharmaceutical
pSivida
Clearside Biomedical
Bausch Health
AptarGroup
Boehringer Ingelheim
Allergan plc
Re-Vana Therapeutics
PolyActiva
Genentech Inc

Biodurable Ophthalmic Drug Delivery System Market Size

The global market for Biodurable Ophthalmic Drug Delivery System was valued at US$ 963 million in the year 2024 and is projected to reach a revised size of US$ 1421 million by 2031, growing at a CAGR of 5.8% during the forecast period.

Biodurable Ophthalmic Drug Delivery System Market

Biodurable Ophthalmic Drug Delivery System Market

Biodurable implants do not break down over time and may be removed or refilled once the treatment is complete.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biodurable Ophthalmic Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biodurable Ophthalmic Drug Delivery System.
The Biodurable Ophthalmic Drug Delivery System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biodurable Ophthalmic Drug Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biodurable Ophthalmic Drug Delivery System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Biodurable Ophthalmic Drug Delivery System Market Report

Report Metric Details
Report Name Biodurable Ophthalmic Drug Delivery System Market
Accounted market size in year US$ 963 million
Forecasted market size in 2031 US$ 1421 million
CAGR 5.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Glaukos Corp, Ocular Therapeutix, Santen Pharmaceutical, pSivida, Clearside Biomedical, Bausch Health, AptarGroup, Boehringer Ingelheim, Allergan, Re-Vana Therapeutics, PolyActiva, Genentech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Biodurable Ophthalmic Drug Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Biodurable Ophthalmic Drug Delivery System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Biodurable Ophthalmic Drug Delivery System Market growing?

Ans: The Biodurable Ophthalmic Drug Delivery System Market witnessing a CAGR of 5.8% during the forecast period 2025-2031.

What is the Biodurable Ophthalmic Drug Delivery System Market size in 2031?

Ans: The Biodurable Ophthalmic Drug Delivery System Market size in 2031 will be US$ 1421 million.

Who are the main players in the Biodurable Ophthalmic Drug Delivery System Market report?

Ans: The main players in the Biodurable Ophthalmic Drug Delivery System Market are Glaukos Corp, Ocular Therapeutix, Santen Pharmaceutical, pSivida, Clearside Biomedical, Bausch Health, AptarGroup, Boehringer Ingelheim, Allergan, Re-Vana Therapeutics, PolyActiva, Genentech

What are the Application segmentation covered in the Biodurable Ophthalmic Drug Delivery System Market report?

Ans: The Applications covered in the Biodurable Ophthalmic Drug Delivery System Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Biodurable Ophthalmic Drug Delivery System Market report?

Ans: The Types covered in the Biodurable Ophthalmic Drug Delivery System Market report are Anterior Drug Delivery Methods, Posterior Drug Delivery Methods

Recommended Reports

Ophthalmic Drug Delivery

Drug Delivery Technologies

Ophthalmic Disease Therapies

1 Biodurable Ophthalmic Drug Delivery System Market Overview
1.1 Product Definition
1.2 Biodurable Ophthalmic Drug Delivery System by Type
1.2.1 Global Biodurable Ophthalmic Drug Delivery System Market Value Comparison by Type (2024 VS 2031)
1.2.2 Anterior Drug Delivery Methods
1.2.3 Posterior Drug Delivery Methods
1.3 Biodurable Ophthalmic Drug Delivery System by Application
1.3.1 Global Biodurable Ophthalmic Drug Delivery System Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Biodurable Ophthalmic Drug Delivery System Market Size Estimates and Forecasts
1.4.1 Global Biodurable Ophthalmic Drug Delivery System Revenue 2020-2031
1.4.2 Global Biodurable Ophthalmic Drug Delivery System Sales 2020-2031
1.4.3 Global Biodurable Ophthalmic Drug Delivery System Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Biodurable Ophthalmic Drug Delivery System Market Competition by Manufacturers
2.1 Global Biodurable Ophthalmic Drug Delivery System Sales Market Share by Manufacturers (2020-2025)
2.2 Global Biodurable Ophthalmic Drug Delivery System Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Biodurable Ophthalmic Drug Delivery System Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Biodurable Ophthalmic Drug Delivery System, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Biodurable Ophthalmic Drug Delivery System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biodurable Ophthalmic Drug Delivery System, Product Type & Application
2.7 Global Key Manufacturers of Biodurable Ophthalmic Drug Delivery System, Date of Enter into This Industry
2.8 Global Biodurable Ophthalmic Drug Delivery System Market Competitive Situation and Trends
2.8.1 Global Biodurable Ophthalmic Drug Delivery System Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Biodurable Ophthalmic Drug Delivery System Players Market Share by Revenue
2.8.3 Global Biodurable Ophthalmic Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Biodurable Ophthalmic Drug Delivery System Market Scenario by Region
3.1 Global Biodurable Ophthalmic Drug Delivery System Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Biodurable Ophthalmic Drug Delivery System Sales by Region: 2020-2031
3.2.1 Global Biodurable Ophthalmic Drug Delivery System Sales by Region: 2020-2025
3.2.2 Global Biodurable Ophthalmic Drug Delivery System Sales by Region: 2026-2031
3.3 Global Biodurable Ophthalmic Drug Delivery System Revenue by Region: 2020-2031
3.3.1 Global Biodurable Ophthalmic Drug Delivery System Revenue by Region: 2020-2025
3.3.2 Global Biodurable Ophthalmic Drug Delivery System Revenue by Region: 2026-2031
3.4 North America Biodurable Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.4.1 North America Biodurable Ophthalmic Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Biodurable Ophthalmic Drug Delivery System Sales by Country (2020-2031)
3.4.3 North America Biodurable Ophthalmic Drug Delivery System Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Biodurable Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.5.1 Europe Biodurable Ophthalmic Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Biodurable Ophthalmic Drug Delivery System Sales by Country (2020-2031)
3.5.3 Europe Biodurable Ophthalmic Drug Delivery System Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biodurable Ophthalmic Drug Delivery System Market Facts & Figures by Region
3.6.1 Asia Pacific Biodurable Ophthalmic Drug Delivery System Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Biodurable Ophthalmic Drug Delivery System Sales by Region (2020-2031)
3.6.3 Asia Pacific Biodurable Ophthalmic Drug Delivery System Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Biodurable Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.7.1 Latin America Biodurable Ophthalmic Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Biodurable Ophthalmic Drug Delivery System Sales by Country (2020-2031)
3.7.3 Latin America Biodurable Ophthalmic Drug Delivery System Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Biodurable Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.8.1 Middle East and Africa Biodurable Ophthalmic Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Biodurable Ophthalmic Drug Delivery System Sales by Country (2020-2031)
3.8.3 Middle East and Africa Biodurable Ophthalmic Drug Delivery System Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Biodurable Ophthalmic Drug Delivery System Sales by Type (2020-2031)
4.1.1 Global Biodurable Ophthalmic Drug Delivery System Sales by Type (2020-2025)
4.1.2 Global Biodurable Ophthalmic Drug Delivery System Sales by Type (2026-2031)
4.1.3 Global Biodurable Ophthalmic Drug Delivery System Sales Market Share by Type (2020-2031)
4.2 Global Biodurable Ophthalmic Drug Delivery System Revenue by Type (2020-2031)
4.2.1 Global Biodurable Ophthalmic Drug Delivery System Revenue by Type (2020-2025)
4.2.2 Global Biodurable Ophthalmic Drug Delivery System Revenue by Type (2026-2031)
4.2.3 Global Biodurable Ophthalmic Drug Delivery System Revenue Market Share by Type (2020-2031)
4.3 Global Biodurable Ophthalmic Drug Delivery System Price by Type (2020-2031)
5 Segment by Application
5.1 Global Biodurable Ophthalmic Drug Delivery System Sales by Application (2020-2031)
5.1.1 Global Biodurable Ophthalmic Drug Delivery System Sales by Application (2020-2025)
5.1.2 Global Biodurable Ophthalmic Drug Delivery System Sales by Application (2026-2031)
5.1.3 Global Biodurable Ophthalmic Drug Delivery System Sales Market Share by Application (2020-2031)
5.2 Global Biodurable Ophthalmic Drug Delivery System Revenue by Application (2020-2031)
5.2.1 Global Biodurable Ophthalmic Drug Delivery System Revenue by Application (2020-2025)
5.2.2 Global Biodurable Ophthalmic Drug Delivery System Revenue by Application (2026-2031)
5.2.3 Global Biodurable Ophthalmic Drug Delivery System Revenue Market Share by Application (2020-2031)
5.3 Global Biodurable Ophthalmic Drug Delivery System Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Glaukos Corp
6.1.1 Glaukos Corp Company Information
6.1.2 Glaukos Corp Description and Business Overview
6.1.3 Glaukos Corp Biodurable Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Glaukos Corp Biodurable Ophthalmic Drug Delivery System Product Portfolio
6.1.5 Glaukos Corp Recent Developments/Updates
6.2 Ocular Therapeutix
6.2.1 Ocular Therapeutix Company Information
6.2.2 Ocular Therapeutix Description and Business Overview
6.2.3 Ocular Therapeutix Biodurable Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Ocular Therapeutix Biodurable Ophthalmic Drug Delivery System Product Portfolio
6.2.5 Ocular Therapeutix Recent Developments/Updates
6.3 Santen Pharmaceutical
6.3.1 Santen Pharmaceutical Company Information
6.3.2 Santen Pharmaceutical Description and Business Overview
6.3.3 Santen Pharmaceutical Biodurable Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Santen Pharmaceutical Biodurable Ophthalmic Drug Delivery System Product Portfolio
6.3.5 Santen Pharmaceutical Recent Developments/Updates
6.4 pSivida
6.4.1 pSivida Company Information
6.4.2 pSivida Description and Business Overview
6.4.3 pSivida Biodurable Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.4.4 pSivida Biodurable Ophthalmic Drug Delivery System Product Portfolio
6.4.5 pSivida Recent Developments/Updates
6.5 Clearside Biomedical
6.5.1 Clearside Biomedical Company Information
6.5.2 Clearside Biomedical Description and Business Overview
6.5.3 Clearside Biomedical Biodurable Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Clearside Biomedical Biodurable Ophthalmic Drug Delivery System Product Portfolio
6.5.5 Clearside Biomedical Recent Developments/Updates
6.6 Bausch Health
6.6.1 Bausch Health Company Information
6.6.2 Bausch Health Description and Business Overview
6.6.3 Bausch Health Biodurable Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bausch Health Biodurable Ophthalmic Drug Delivery System Product Portfolio
6.6.5 Bausch Health Recent Developments/Updates
6.7 AptarGroup
6.7.1 AptarGroup Company Information
6.7.2 AptarGroup Description and Business Overview
6.7.3 AptarGroup Biodurable Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.7.4 AptarGroup Biodurable Ophthalmic Drug Delivery System Product Portfolio
6.7.5 AptarGroup Recent Developments/Updates
6.8 Boehringer Ingelheim
6.8.1 Boehringer Ingelheim Company Information
6.8.2 Boehringer Ingelheim Description and Business Overview
6.8.3 Boehringer Ingelheim Biodurable Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Boehringer Ingelheim Biodurable Ophthalmic Drug Delivery System Product Portfolio
6.8.5 Boehringer Ingelheim Recent Developments/Updates
6.9 Allergan
6.9.1 Allergan Company Information
6.9.2 Allergan Description and Business Overview
6.9.3 Allergan Biodurable Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Allergan Biodurable Ophthalmic Drug Delivery System Product Portfolio
6.9.5 Allergan Recent Developments/Updates
6.10 Re-Vana Therapeutics
6.10.1 Re-Vana Therapeutics Company Information
6.10.2 Re-Vana Therapeutics Description and Business Overview
6.10.3 Re-Vana Therapeutics Biodurable Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Re-Vana Therapeutics Biodurable Ophthalmic Drug Delivery System Product Portfolio
6.10.5 Re-Vana Therapeutics Recent Developments/Updates
6.11 PolyActiva
6.11.1 PolyActiva Company Information
6.11.2 PolyActiva Description and Business Overview
6.11.3 PolyActiva Biodurable Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.11.4 PolyActiva Biodurable Ophthalmic Drug Delivery System Product Portfolio
6.11.5 PolyActiva Recent Developments/Updates
6.12 Genentech
6.12.1 Genentech Company Information
6.12.2 Genentech Description and Business Overview
6.12.3 Genentech Biodurable Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Genentech Biodurable Ophthalmic Drug Delivery System Product Portfolio
6.12.5 Genentech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biodurable Ophthalmic Drug Delivery System Industry Chain Analysis
7.2 Biodurable Ophthalmic Drug Delivery System Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biodurable Ophthalmic Drug Delivery System Production Mode & Process Analysis
7.4 Biodurable Ophthalmic Drug Delivery System Sales and Marketing
7.4.1 Biodurable Ophthalmic Drug Delivery System Sales Channels
7.4.2 Biodurable Ophthalmic Drug Delivery System Distributors
7.5 Biodurable Ophthalmic Drug Delivery System Customer Analysis
8 Biodurable Ophthalmic Drug Delivery System Market Dynamics
8.1 Biodurable Ophthalmic Drug Delivery System Industry Trends
8.2 Biodurable Ophthalmic Drug Delivery System Market Drivers
8.3 Biodurable Ophthalmic Drug Delivery System Market Challenges
8.4 Biodurable Ophthalmic Drug Delivery System Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Glaukos Corp
Ocular Therapeutix
Santen Pharmaceutical
pSivida
Clearside Biomedical
Bausch Health
AptarGroup
Boehringer Ingelheim
Allergan plc
Re-Vana Therapeutics
PolyActiva
Genentech Inc
List of Tables
 Table 1. Global Biodurable Ophthalmic Drug Delivery System Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Biodurable Ophthalmic Drug Delivery System Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Biodurable Ophthalmic Drug Delivery System Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Biodurable Ophthalmic Drug Delivery System Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Biodurable Ophthalmic Drug Delivery System Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Biodurable Ophthalmic Drug Delivery System Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Biodurable Ophthalmic Drug Delivery System Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Biodurable Ophthalmic Drug Delivery System Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Biodurable Ophthalmic Drug Delivery System, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Biodurable Ophthalmic Drug Delivery System, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Biodurable Ophthalmic Drug Delivery System, Product Type & Application
 Table 12. Global Key Manufacturers of Biodurable Ophthalmic Drug Delivery System, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Biodurable Ophthalmic Drug Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biodurable Ophthalmic Drug Delivery System as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Biodurable Ophthalmic Drug Delivery System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Biodurable Ophthalmic Drug Delivery System Sales by Region (2020-2025) & (K Units)
 Table 18. Global Biodurable Ophthalmic Drug Delivery System Sales Market Share by Region (2020-2025)
 Table 19. Global Biodurable Ophthalmic Drug Delivery System Sales by Region (2026-2031) & (K Units)
 Table 20. Global Biodurable Ophthalmic Drug Delivery System Sales Market Share by Region (2026-2031)
 Table 21. Global Biodurable Ophthalmic Drug Delivery System Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Biodurable Ophthalmic Drug Delivery System Revenue Market Share by Region (2020-2025)
 Table 23. Global Biodurable Ophthalmic Drug Delivery System Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Biodurable Ophthalmic Drug Delivery System Revenue Market Share by Region (2026-2031)
 Table 25. North America Biodurable Ophthalmic Drug Delivery System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Biodurable Ophthalmic Drug Delivery System Sales by Country (2020-2025) & (K Units)
 Table 27. North America Biodurable Ophthalmic Drug Delivery System Sales by Country (2026-2031) & (K Units)
 Table 28. North America Biodurable Ophthalmic Drug Delivery System Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Biodurable Ophthalmic Drug Delivery System Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Biodurable Ophthalmic Drug Delivery System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Biodurable Ophthalmic Drug Delivery System Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Biodurable Ophthalmic Drug Delivery System Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Biodurable Ophthalmic Drug Delivery System Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Biodurable Ophthalmic Drug Delivery System Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Biodurable Ophthalmic Drug Delivery System Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Biodurable Ophthalmic Drug Delivery System Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Biodurable Ophthalmic Drug Delivery System Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Biodurable Ophthalmic Drug Delivery System Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Biodurable Ophthalmic Drug Delivery System Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Biodurable Ophthalmic Drug Delivery System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Biodurable Ophthalmic Drug Delivery System Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Biodurable Ophthalmic Drug Delivery System Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Biodurable Ophthalmic Drug Delivery System Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Biodurable Ophthalmic Drug Delivery System Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Biodurable Ophthalmic Drug Delivery System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Biodurable Ophthalmic Drug Delivery System Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Biodurable Ophthalmic Drug Delivery System Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Biodurable Ophthalmic Drug Delivery System Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Biodurable Ophthalmic Drug Delivery System Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Biodurable Ophthalmic Drug Delivery System Sales (K Units) by Type (2020-2025)
 Table 51. Global Biodurable Ophthalmic Drug Delivery System Sales (K Units) by Type (2026-2031)
 Table 52. Global Biodurable Ophthalmic Drug Delivery System Sales Market Share by Type (2020-2025)
 Table 53. Global Biodurable Ophthalmic Drug Delivery System Sales Market Share by Type (2026-2031)
 Table 54. Global Biodurable Ophthalmic Drug Delivery System Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Biodurable Ophthalmic Drug Delivery System Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Biodurable Ophthalmic Drug Delivery System Revenue Market Share by Type (2020-2025)
 Table 57. Global Biodurable Ophthalmic Drug Delivery System Revenue Market Share by Type (2026-2031)
 Table 58. Global Biodurable Ophthalmic Drug Delivery System Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Biodurable Ophthalmic Drug Delivery System Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Biodurable Ophthalmic Drug Delivery System Sales (K Units) by Application (2020-2025)
 Table 61. Global Biodurable Ophthalmic Drug Delivery System Sales (K Units) by Application (2026-2031)
 Table 62. Global Biodurable Ophthalmic Drug Delivery System Sales Market Share by Application (2020-2025)
 Table 63. Global Biodurable Ophthalmic Drug Delivery System Sales Market Share by Application (2026-2031)
 Table 64. Global Biodurable Ophthalmic Drug Delivery System Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Biodurable Ophthalmic Drug Delivery System Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Biodurable Ophthalmic Drug Delivery System Revenue Market Share by Application (2020-2025)
 Table 67. Global Biodurable Ophthalmic Drug Delivery System Revenue Market Share by Application (2026-2031)
 Table 68. Global Biodurable Ophthalmic Drug Delivery System Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Biodurable Ophthalmic Drug Delivery System Price (US$/Unit) by Application (2026-2031)
 Table 70. Glaukos Corp Company Information
 Table 71. Glaukos Corp Description and Business Overview
 Table 72. Glaukos Corp Biodurable Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Glaukos Corp Biodurable Ophthalmic Drug Delivery System Product
 Table 74. Glaukos Corp Recent Developments/Updates
 Table 75. Ocular Therapeutix Company Information
 Table 76. Ocular Therapeutix Description and Business Overview
 Table 77. Ocular Therapeutix Biodurable Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Ocular Therapeutix Biodurable Ophthalmic Drug Delivery System Product
 Table 79. Ocular Therapeutix Recent Developments/Updates
 Table 80. Santen Pharmaceutical Company Information
 Table 81. Santen Pharmaceutical Description and Business Overview
 Table 82. Santen Pharmaceutical Biodurable Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Santen Pharmaceutical Biodurable Ophthalmic Drug Delivery System Product
 Table 84. Santen Pharmaceutical Recent Developments/Updates
 Table 85. pSivida Company Information
 Table 86. pSivida Description and Business Overview
 Table 87. pSivida Biodurable Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. pSivida Biodurable Ophthalmic Drug Delivery System Product
 Table 89. pSivida Recent Developments/Updates
 Table 90. Clearside Biomedical Company Information
 Table 91. Clearside Biomedical Description and Business Overview
 Table 92. Clearside Biomedical Biodurable Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Clearside Biomedical Biodurable Ophthalmic Drug Delivery System Product
 Table 94. Clearside Biomedical Recent Developments/Updates
 Table 95. Bausch Health Company Information
 Table 96. Bausch Health Description and Business Overview
 Table 97. Bausch Health Biodurable Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Bausch Health Biodurable Ophthalmic Drug Delivery System Product
 Table 99. Bausch Health Recent Developments/Updates
 Table 100. AptarGroup Company Information
 Table 101. AptarGroup Description and Business Overview
 Table 102. AptarGroup Biodurable Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. AptarGroup Biodurable Ophthalmic Drug Delivery System Product
 Table 104. AptarGroup Recent Developments/Updates
 Table 105. Boehringer Ingelheim Company Information
 Table 106. Boehringer Ingelheim Description and Business Overview
 Table 107. Boehringer Ingelheim Biodurable Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Boehringer Ingelheim Biodurable Ophthalmic Drug Delivery System Product
 Table 109. Boehringer Ingelheim Recent Developments/Updates
 Table 110. Allergan Company Information
 Table 111. Allergan Description and Business Overview
 Table 112. Allergan Biodurable Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Allergan Biodurable Ophthalmic Drug Delivery System Product
 Table 114. Allergan Recent Developments/Updates
 Table 115. Re-Vana Therapeutics Company Information
 Table 116. Re-Vana Therapeutics Description and Business Overview
 Table 117. Re-Vana Therapeutics Biodurable Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Re-Vana Therapeutics Biodurable Ophthalmic Drug Delivery System Product
 Table 119. Re-Vana Therapeutics Recent Developments/Updates
 Table 120. PolyActiva Company Information
 Table 121. PolyActiva Description and Business Overview
 Table 122. PolyActiva Biodurable Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. PolyActiva Biodurable Ophthalmic Drug Delivery System Product
 Table 124. PolyActiva Recent Developments/Updates
 Table 125. Genentech Company Information
 Table 126. Genentech Description and Business Overview
 Table 127. Genentech Biodurable Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Genentech Biodurable Ophthalmic Drug Delivery System Product
 Table 129. Genentech Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Biodurable Ophthalmic Drug Delivery System Distributors List
 Table 133. Biodurable Ophthalmic Drug Delivery System Customers List
 Table 134. Biodurable Ophthalmic Drug Delivery System Market Trends
 Table 135. Biodurable Ophthalmic Drug Delivery System Market Drivers
 Table 136. Biodurable Ophthalmic Drug Delivery System Market Challenges
 Table 137. Biodurable Ophthalmic Drug Delivery System Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Biodurable Ophthalmic Drug Delivery System
 Figure 2. Global Biodurable Ophthalmic Drug Delivery System Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Biodurable Ophthalmic Drug Delivery System Market Share by Type: 2024 & 2031
 Figure 4. Anterior Drug Delivery Methods Product Picture
 Figure 5. Posterior Drug Delivery Methods Product Picture
 Figure 6. Global Biodurable Ophthalmic Drug Delivery System Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Biodurable Ophthalmic Drug Delivery System Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Clinics
 Figure 10. Others
 Figure 11. Global Biodurable Ophthalmic Drug Delivery System Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Biodurable Ophthalmic Drug Delivery System Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Biodurable Ophthalmic Drug Delivery System Sales (2020-2031) & (K Units)
 Figure 14. Global Biodurable Ophthalmic Drug Delivery System Average Price (US$/Unit) & (2020-2031)
 Figure 15. Biodurable Ophthalmic Drug Delivery System Report Years Considered
 Figure 16. Biodurable Ophthalmic Drug Delivery System Sales Share by Manufacturers in 2024
 Figure 17. Global Biodurable Ophthalmic Drug Delivery System Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Biodurable Ophthalmic Drug Delivery System Players: Market Share by Revenue in Biodurable Ophthalmic Drug Delivery System in 2024
 Figure 19. Biodurable Ophthalmic Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Biodurable Ophthalmic Drug Delivery System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Biodurable Ophthalmic Drug Delivery System Sales Market Share by Country (2020-2031)
 Figure 22. North America Biodurable Ophthalmic Drug Delivery System Revenue Market Share by Country (2020-2031)
 Figure 23. United States Biodurable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Biodurable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Biodurable Ophthalmic Drug Delivery System Sales Market Share by Country (2020-2031)
 Figure 26. Europe Biodurable Ophthalmic Drug Delivery System Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Biodurable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Biodurable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Biodurable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Biodurable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Biodurable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Biodurable Ophthalmic Drug Delivery System Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Biodurable Ophthalmic Drug Delivery System Revenue Market Share by Region (2020-2031)
 Figure 34. China Biodurable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Biodurable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Biodurable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Biodurable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Biodurable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Biodurable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Biodurable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Biodurable Ophthalmic Drug Delivery System Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Biodurable Ophthalmic Drug Delivery System Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Biodurable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Biodurable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Biodurable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Biodurable Ophthalmic Drug Delivery System Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Biodurable Ophthalmic Drug Delivery System Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Biodurable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Biodurable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Biodurable Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Biodurable Ophthalmic Drug Delivery System by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Biodurable Ophthalmic Drug Delivery System by Type (2020-2031)
 Figure 53. Global Biodurable Ophthalmic Drug Delivery System Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Biodurable Ophthalmic Drug Delivery System by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Biodurable Ophthalmic Drug Delivery System by Application (2020-2031)
 Figure 56. Global Biodurable Ophthalmic Drug Delivery System Price (US$/Unit) by Application (2020-2031)
 Figure 57. Biodurable Ophthalmic Drug Delivery System Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Biodurable Ocular Implant Market Research Report 2025
Global Bioresorbable Ophthalmic Drug Delivery System Market Research Report 2025
Global Bioresorbable Ocular Implant Market Research Report 2025
Global Biodegradable Ocular Implant Market Research Report 2025
Global Biodegradable Implantable Drug Delivery System Market Research Report 2024
Global Implantable Ophthalmic Drugs Market Research Report 2025
Global Non biodegradable Implantable Drug Delivery System Market Research Report 2024
Global Soft Implantable Drug Delivery System Market Research Report 2024
Global Bioabsorbable Implants Market Research Report 2024
Global Ophthalmic Implant Products Market Research Report 2024
Global Implantable and Needle Free Drug Delivery Market Research Report 2024
Resorbable Fixation Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Implantable Ophthalmic Medical Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bioabsorbable Surgical Implant Market Research Report 2025
Medical Implantable Drug Delivery Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sustained Release Ocular Drug Delivery Systems Market Research Report 2025
Global Ophthalmic Multidose System Market Research Report 2024
Ophthalmic Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bioabsorbable Fiber Tubing and Film Market Research Report 2025
Bio Absorbable Implants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions